Last reviewed · How we verify
Universität Duisburg-Essen — Portfolio Competitive Intelligence Brief
1 marketed
0 filed
1 Phase 3
0 Phase 2
0 Phase 1
Live · 30-min refresh
Portfolio leaders (marketed + Phase 3 / filed)
| Drug | Generic | Phase | Class | Target | Area | First approval |
|---|---|---|---|---|---|---|
| caraway oil | caraway oil | marketed | Herbal/botanical preparation | Gastroenterology | ||
| Individualized internal ayurvedic treatment | Individualized internal ayurvedic treatment | phase 3 |
Therapeutic area mix
- Gastroenterology · 1
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Competitive overlap (companies sharing drug classes)
- Rosenberg European Academy of Ayurveda · 1 shared drug class
- Weleda AG · 1 shared drug class
Subscribe to ongoing alerts
Every new pipeline event for Universität Duisburg-Essen:
- Universität Duisburg-Essen pipeline updates — RSS
- Universität Duisburg-Essen pipeline updates — Atom
- Universität Duisburg-Essen pipeline updates — JSON
Cite this brief
Drug Landscape (2026). Universität Duisburg-Essen — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/universit-t-duisburg-essen. Accessed 2026-05-17.